Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 9, 2001, Pages 1375-1384

  Netzer, P ^a   Gut, A ^a   Brundler, R ^a   Gaia, C ^a   Halter, F ^a   Inauen, W ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Gastrointestinal Unit   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; BILE REFLUX; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS MOTILITY; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SCORING SYSTEM; WOUND HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BENZIMIDAZOLES; BILE REFLUX; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HELICOBACTER PYLORI; HUMANS; MALE; MANOMETRY; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; SULFOXIDES;

EID: 0034846875     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01069.x     Document Type: Article

References (63)

1. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
2. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia
3. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
4. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats
5. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen
6. Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis - Experimental model in Wistar female rats
7. Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats
8. Role of acid and duodenogastric reflux in esophageal mucosal injury: A review of animal and human studies
9. Bile in the oesophagus: Clinical relevance and ambulatory detection
10. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's oesophagus
11. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux
12. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized
13. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus
14. Assessment of non-acid esophageal reflux: Comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring
15. Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity
16. Double reflux: Double trouble
17. Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion
18. Investigation of oesophageal reflux symptoms after gastric surgery with combined pH and bilirubin monitoring
19. Contribution of acid and duodenogastrooesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients
20. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients
21. Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus
22. Effect of omeprazole 20 mg twice daily on duodenogastric and gastroeosophageal bile reflux in Barrett's oesophagus
23. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: A 24 hour ambulatory combined pH and manometry study
24. Five-year audit of ambulatory 24-hour esophageal pH-manometry in clinical practice
25. Ineffective esophageal motility: The most common motility abnormality in patients with GERD-associated respiratory symptoms
26. Esophageal motor abnormalities in gastroesophageal reflux and the effects of fundoplication
27. Healing of severe esophagitis improves esophageal peristaltic dysfunction
28. Does oesophageal motor function improve with time after successful antireflux surgery? Results of a prospective, randomized clinical study
29. The effect of healing oesophagitis on oesophageal motor function as determined by oesophageal scintigraphy and ambulatory oesophageal motility/pH monitoring
30. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans
31. Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer
32. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: A European multicentre study
33. Oral pantoprazole for erosive esophagitis: A placebo-controlled, randomized clinical trial
34. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis
35. Symptoms in gastro-oesophageal reflux disease
36. The relationship between acid and bile reflux and symptoms in gastrooesophageal reflux disease
37. The esophagus
38. Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique
39. Which pH threshold is best in esophageal pH monitoring?
40. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease
41. Ambulatory 24-h esophageal pH monitoring: Normal values, optimal thresholds, specifity, sensitivity, and reproducibility
42. Characteristics of distal partial gastrectomy patients with esophageal symptoms of duodenogastric reflux
43. Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade
44. The temporal relationship between oesophagus bile reflux and pH in gastro-oesophageal reflux disease
45. The effect of omeprazole on gastric emptying in patients with duodenal ulcer disease
46. The effects of omeprazole on intragastric pH, intestinal motility and gastric emptying rate
47. Helicobacter pylori may induce bile reflux: Link between H. pylori and bile induced injury to gastric epithelium
48. Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types?
49. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection
50. Increased gastric juice nitrate is associated with biliary reflux and Helicobacter pylori infection
51. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma
52. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
53. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
54. H. pylori and cagA: Relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications
55. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough
56. Indications for results and consequences of 24-hour esophageal pH monitoring
57. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus
58. Association of hiatal hernia and gastroesophageal reflux: Correlation between presence and size of hiatal hernia and 24-hour pH monitoring of the esophagus
59. Barrett's esophagus: Prevalence and size of hiatal hernia
60. Association of obesity with hiatal hernia and esophagitis
61. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight
62. Association between body mass and adenocarcinoma of the esophagus and gastric cardia
63. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia